<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>09001570549785</udiDi>
    <basicUdiDi>9001570N*F-030VB-N-3RB</basicUdiDi>
    <tradeName>sempermed velvet (100)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015967</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.879Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549815</udiDi>
    <basicUdiDi>9001570N*F-030VB-N-3RB</basicUdiDi>
    <tradeName>sempermed velvet (100)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015968</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.862Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549839</udiDi>
    <basicUdiDi>9001570N*F-030VB-N-3RB</basicUdiDi>
    <tradeName>sempermed velvet (100)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015969</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.851Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549846</udiDi>
    <basicUdiDi>9001570N*F-030VB-N-3RB</basicUdiDi>
    <tradeName>sempermed velvet (100)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015970</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.834Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549860</udiDi>
    <basicUdiDi>9001570N*F-035VB-N-3TY</basicUdiDi>
    <tradeName>sempermed velvet XP (100)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015971</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.821Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549891</udiDi>
    <basicUdiDi>9001570N*F-035VB-N-3TY</basicUdiDi>
    <tradeName>sempermed velvet XP (100)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015972</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.806Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549914</udiDi>
    <basicUdiDi>9001570N*F-035VB-N-3TY</basicUdiDi>
    <tradeName>sempermed velvet XP (100)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015973</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.793Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549938</udiDi>
    <basicUdiDi>9001570N*F-035VB-N-3TY</basicUdiDi>
    <tradeName>sempermed velvet XP (100)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015974</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.780Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549945</udiDi>
    <basicUdiDi>9001570N*F-035VB-N-3TY</basicUdiDi>
    <tradeName>sempermed velvet XP (100)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015975</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.768Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549969</udiDi>
    <basicUdiDi>9001570N*F-030VB-N-3RB</basicUdiDi>
    <tradeName>semperguard sapphire (100)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015982</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.756Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570549983</udiDi>
    <basicUdiDi>9001570N*F-030VB-N-3RB</basicUdiDi>
    <tradeName>semperguard sapphire (100)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015983</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.743Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570550002</udiDi>
    <basicUdiDi>9001570N*F-030VB-N-3RB</basicUdiDi>
    <tradeName>semperguard sapphire (100)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015984</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.730Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570550026</udiDi>
    <basicUdiDi>9001570N*F-030VB-N-3RB</basicUdiDi>
    <tradeName>semperguard sapphire (100)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015985</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.715Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570550040</udiDi>
    <basicUdiDi>9001570N*F-030VB-N-3RB</basicUdiDi>
    <tradeName>semperguard sapphire (100)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015986</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.699Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570550064</udiDi>
    <basicUdiDi>9001570N*F-030VB-N-3RB</basicUdiDi>
    <tradeName>semperguard sapphire (100)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015987</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.682Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570550095</udiDi>
    <basicUdiDi>9001570N*F-035VB-N-3TY</basicUdiDi>
    <tradeName>sempermed velvet XP (200)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015991</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.658Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570550118</udiDi>
    <basicUdiDi>9001570N*F-035VB-N-3TY</basicUdiDi>
    <tradeName>sempermed velvet XP (200)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015992</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.643Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570550132</udiDi>
    <basicUdiDi>9001570N*F-035VB-N-3TY</basicUdiDi>
    <tradeName>sempermed velvet XP (200)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015993</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.626Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570550149</udiDi>
    <basicUdiDi>9001570N*F-035VB-N-3TY</basicUdiDi>
    <tradeName>sempermed velvet XP (200)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015994</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.615Z</lastUpdated>
  </row>
  <row>
    <udiDi>09001570550170</udiDi>
    <basicUdiDi>9001570N*F-035VB-N-3TY</basicUdiDi>
    <tradeName>sempermed velvet XP (200)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>HARPS Investment Asia Pte. Ltd.</manufacturerName>
    <manufacturerSrn>SG-MF-000001645</manufacturerSrn>
    <authorisedRepresentativeName>HARPS Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>AT-AR-000040870</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>T01020204</emdnCode>
    <emdnDescription>NITRILE EXAMINATION / TREATMENT GLOVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3000015995</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-01T08:14:44.606Z</lastUpdated>
  </row>
</eudamedExport>